← FDA Drug Approvals (Drugs@FDA)

LAPATINIB DITOSYLATE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: NATCO PHARMA LTD · Approved 2020-09-29

Drug application

FDA Application #

ANDA203007

Application type

Abbreviated New Drug Application (Generic)

Brand name

LAPATINIB DITOSYLATE

Generic name

LAPATINIB

Active ingredients

LAPATINIB DITOSYLATE

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

NATCO PHARMA LTD

Manufacturer

Lupin Pharmaceuticals, Inc.

First approval

2020-09-29

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown